Palmitoylethanolamide in the treatment of chronic pain: a systematic review and meta-analysis of double-blind randomized controlled trials

K Lang-Illievich, C Klivinyi, C Lasser, CTA Brenna… - Nutrients, 2023 - mdpi.com
Chronic pain is a major source of morbidity for which there are limited effective treatments.
Palmitoylethanolamide (PEA), a naturally occurring fatty acid amide, has demonstrated utility …

The role of the pharmacist in the care of patients with chronic pain

L Murphy, K Ng, P Isaac, J Swidrovich… - Integrated Pharmacy …, 2021 - Taylor & Francis
Pharmacists across the healthcare continuum are well positioned to collaborate with
patients to effectively manage their chronic pain. Evidence supports positive outcomes when …

The effect of palmitoylethanolamide on pain intensity, central and peripheral sensitization, and pain modulation in healthy volunteers—a randomized, double-blinded …

K Lang-Illievich, C Klivinyi, G Rumpold-Seitlinger… - Nutrients, 2022 - mdpi.com
Palmitoylethanolamide (PEA) is marketed as a “dietary food for special medical purposes”.
Its broad-spectrum analgesic, anti-inflammatory, and neuroprotective effects make PEA an …

[HTML][HTML] QT prolongation in HIV-positive patients

J Liu, SK Shah, I Basu-Ray, J Garcia-Diaz, K Khalid… - Indian Heart …, 2019 - Elsevier
Introduction Antiretrovirals have immensely increased the average life expectancy of HIV-
positive patients. However, the incidence of QT interval prolongation and other arrhythmias …

[HTML][HTML] Opioid-induced constipation: a narrative review of therapeutic options in clinical management

K Lang-Illievich… - The Korean journal of …, 2019 - synapse.koreamed.org
Pain therapy often entails gastrointestinal adverse events. While opioids are effective drugs
for pain relief, the incidence of opioid-induced constipation (OIC) varies greatly from 15% to …

Management of anaphylaxis and allergies in patients with long QT syndrome: A review of the current evidence

T Welzel, VC Ziesenitz, S Seitz, B Donner… - Annals of Allergy …, 2018 - Elsevier
Objective To develop a treatment algorithm for patients with long QT syndrome (LQTS) in
case they need antiallergic medications for allergic reactions, including asthma and …

Analgesic drugs and cardiac safety

G Varrassi, J Pergolizzi, JF Peppin, A Paladini - Brain and heart dynamics, 2020 - Springer
Acute pain may become very dangerous for the cardiac function. Its rapid and efficacious
treatment is important to prevent serious cardiac complications, especially in patients with …

Perianesthesia implications and considerations for drug-induced Qt interval prolongation

EN Aroke, RZ Nkemazeh - Journal of PeriAnesthesia Nursing, 2020 - Elsevier
Prolongation of the QT interval can predispose patients to fatal arrhythmias such as torsade
de pointes. While arrhythmias can occur spontaneously in patients with a genetic …

[PDF][PDF] QT interval prolongation: life-threatening consequences of life saving drugs

SK Shah - Pharm Drug Dev Ther, 2018 - siriusstore.com
Acquired long QT syndrome is a frequent phenomenon in clinical practice. QT interval
prolongation can lead to fatal ventricular arrhythmias and even sudden cardiac death …

Приобретенное удлинение интервала QT у спортсменов

АС Юнисова, АВ Смоленский - Спортивная медицина: наука и …, 2022 - smjournal.ru
Аннотация Синдром удлиненного синдрома QT (LQTS)—часто встречаемое
нарушение состояния, приводящее к драматичным для пациентов исходам, главным из …